Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma ; volume:4 ; number:1 ; day:15 ; month:11 ; year:2016 ; pages:1-15 ; date:12.2016
Journal for ImmunoTherapy of Cancer ; 4, Heft 1 (15.11.2016), 1-15, 12.2016
- Creator
-
Rini, Brian I.
- Contributor
-
McDermott, David F.
Hammers, Hans
Bro, William
Bukowski, Ronald M.
Faba, Bernard
Faba, Jo
Figlin, Robert A.
Hutson, Thomas
Jonasch, Eric
Joseph, Richard W.
Leibovich, Bradley C.
Olencki, Thomas
Pantuck, Allan J.
Quinn, David I.
Seery, Virginia
Voss, Martin H.
Wood, Christopher G.
Wood, Laura S.
Atkins, Michael B.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-016-0180-7
- URN
-
urn:nbn:de:1111-201612048256
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rini, Brian I.
- McDermott, David F.
- Hammers, Hans
- Bro, William
- Bukowski, Ronald M.
- Faba, Bernard
- Faba, Jo
- Figlin, Robert A.
- Hutson, Thomas
- Jonasch, Eric
- Joseph, Richard W.
- Leibovich, Bradley C.
- Olencki, Thomas
- Pantuck, Allan J.
- Quinn, David I.
- Seery, Virginia
- Voss, Martin H.
- Wood, Christopher G.
- Wood, Laura S.
- Atkins, Michael B.
- SpringerLink (Online service)
Other Objects (12)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
Immunotherapy for Atherosclerosis—Novel Concepts
Oncolytic viruses for cancer immunotherapy
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
Immunotherapy for Atherosclerosis—Novel Concepts
Oncolytic viruses for cancer immunotherapy
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
Immunotherapy for Atherosclerosis—Novel Concepts